How many clinical trials are tracked of telmisartan?

18 trials are tracked, 2 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Dermatology Urology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

telmisartan

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of telmisartan

18 trials tracked of telmisartan: 11 in phase 3 or 4 and 2 with published results. The most-cited published study has 27 citations.

18Trials tracked

11Phase 3 & 4

0Recruiting

2With published results

Phase distribution

Phase 4 6 Phase 3 5 Phase 2 3 Phase 1 1 Other / NA 3

Phase 4 Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia Completed · 27 cited
Phase 4 A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-R Completed · 20 cited
Phase 4 INTERVENCION Trial Completed
Phase 4 Telmisartan 80mg Plus Hydrochlorothiazide 25mg First Line in Moderate or Severe Hypertension Completed
Phase 4 Efficacy and Safety of Aliskiren 300 mg Compared to Telmisartan 80 mg After 1 Week of Treatment Withdrawal Completed
Phase 4 Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo. Completed

Show 12 more trials

Phase 3 Telmisartan 80mg Non-responder Trial Completed
Phase 3 HALT Progression of Polycystic Kidney Disease Study B Completed
Phase 3 HALT Progression of Polycystic Kidney Disease Study A Completed
Phase 3 Filtered Trial for Telmisartan 40mg Non-responder Completed
Phase 3 Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe Hypertension Completed
Phase 2 A Clinical Trial for People HIV+ Age > 50 at Risk for Heart Disease Completed
Phase 2 HIV and Fat Accumulation Completed
Phase 2 Telmisartan to Reduce AIDS-Related Fibrotic and Inflammatory Contributors (TRAFIC Study) Completed
Phase 1 Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg FDC Tablet and Telmisartan 80 mg Tab and Amlodipine 5 mg Tab Concomitant Use Completed
N/A Twynsta Study With Lifestyle Modifications in Korean Patients With Hypertension Completed
N/A J-TARGET,Japanese Telmisartan Study for Antihypertensive Good Effect in Long Term Observation Completed
N/A Telmisartan Plus Exercise to Improve Functioning in Peripheral Artery Disease Completed

Showing the 18 most-cited and recently-updated of 18 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.